An ecigarette research will work on counting puffs, searching Facebook and measuring how ecigarette displays and price promos will influence whether minors will buy the products or not. A dedicated team will be assigned for each task.
One team will work with volunteer vapers to count puffs and assess ecigarette risks. Another team will search Facebook and look at posts regarding how people tinker with devices to get extra nicotine. A third group will create a virtual convenience store to cater 13-17 years old to measure how ecigarette displays and the price promos will influence whether minors will buy the popular devices.
The budget for this and other 45 ecig researches by the FDA is $270 million in order to determine ecigarette risks before more Americans get hooked on the ecigarettes.
Leading the projects is Dr Suchitra Krishnan-Sarin from Yale University. Final results would not be available until 2018. For this timetable, the slow pace of science will be underscored as contributed by regulatory vacuum. It will allow ecigarette makers to sell their products without challenges.
There are also studies that are not funded by the FDA. The agency could choose 48 projects that they could address questions that are related to future regulations
According to Wells Fargo Securities said that the FDA should wait for results prior to issuing any regulations or manufacturers will be driven out of business because of unproven fears.
According to Attorney Bryan Haynes, there must be no regulations on ecigarettes that are similar to those covering conventional cigarettes unless there are evidences that are similar to those of cigarette’s smoke’s health impact. Haynes’ Richmond, Virginia-based legal firm Troutman Sanders represents the ecigarette manufacturers.
According to an FDA spokeswoman, the agency will always make regulatory decisions that are based on the best scientific evidences available. With ecigarettes, the agency does not think that it will take many years to create the regulatory framework. The FDA has the fundamental authority in regulating the products and it could happen by next year.
The absent science involves basic questions like what compounds are present in the vapor that ecigs produce. It also involves complicated questions such as whether flavors are enticing children; how ecig displays in online stores could affect the desire in buying vaping eliquids. The most crucial question is whether ecigs could reduce the number of smokers or producing a new generation of addicts.
The team from Yale will study if menthol and other flavors like cherry and chocolate increase ecigarette appeal, particularly to 16-18 years old smokers and dual users. If this is the case, the FDA will have specific support for regulations. The first results will be available within 2 years. This will be the first in four to five batches of results.
Real Life Trial
As a public health uncontrolled ecigarette research, ecig use is rivaled by conventional smoking of cigarettes, it was a habit that half of the American men and one quarter of American women adopted in the 1960s. The first Surgeon General reported on the health dangers of smoking.
Right now, over 10 million Americans have died from ailments associated with smoking. Research on ecigs has moved a lot quickly. It is partly due to the desire of scientists to understand the biological effects of vaping.
There is another study that FDA also has funded and will be carried out by the University of Louisville to illustrate the slow pace of science. Three to four brands of ecigs will be analyzed. The volatile compounds will also be analyzed along with flavorings and their particulate matter so that the effect on the lungs and other cells in lab mice could be known. The lead researcher for the study is Dr. Sanjay Srivastata.